Comparisons with a previously developed 26-variant IL6R instrument of IL-6 signaling downregulation15,17,20 revealed directionally consistent results, although there was evidence of larger effects of IL6 perturbation on odds of PAD and IS (P for heterogeneity <0.05; Fig. 4). This evidence concerns the gene IL6R and peripheral arterial disease.